The pharma space has a very prescribed linear process and this is to reduce errors and avoid uncertainties and deviations. With the advent of digital therapeutics, there’s a need to do things differently, to be open to ideas, and to take analogs from different verticals.

In this episode, we have the privilege to host Tai Chung, the Director of Partnerships for ZS Medullan. Tai talks about the challenges of getting pharma manufacturers on communicating the value of digital strategies and the importance of being creative, agile, and having a curiosity-driven mindset when it comes to going digital.  We also covered some of the topics and takeaways from his recent webinar like data sharing,  trends in the pharma value chain, and some solutions foreign markets can innovate along with the key trends.

There’s so much change going on in the pharma space and a lot of challenging new paradigm shifts for the industry and manufacturers, but Tai and his team have a solid understanding of the problem and different solutions to solve it for their customers. Don’t miss this insightful interview with Tia Chung!

Click this link to the show notes, transcript, and resources: outcomesrocket.health